Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Richard

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Thorax|November 1, 2019
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhageMarie-Louise Frémond, Marie Legendre, Michael Fayon, et al.
The Journal of Rheumatology|July 1, 2024
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial SpondyloarthritisSherry Rohekar, Jordi Pardo Pardo, Reza Mirza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2012
An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trialFlorence de Fraipont, Guénaëlle Levallet, Christian Creveuil, et al.
Clinical and Translational Gastroenterology|December 8, 2025
IMPACT OF ENDOMETRIOSIS ON THE PROGRESSION OF INFLAMMATORY BOWEL DISEASES: A MULTICENTER RETROSPECTIVE STUDYLucas Guillo, Oumaya El Oumami, Philippe Seksik, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
The Journal of Rheumatology|July 1, 2025
Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA)Denis Choquette, Dafna D Gladman, Robert D Inman, et al.
Molecular Systems Biology|September 4, 2008
InnateDB: facilitating systems-level analyses of the mammalian innate immune responseDavid J Lynn, Geoffrey L Winsor, Calvin Chan, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1)Michèle Beau-Faller, Armelle Degeorges, Estelle Rolland, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre StudyMathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Thorax|November 1, 2019
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhageMarie-Louise Frémond, Marie Legendre, Michael Fayon, et al.
The Journal of Rheumatology|July 1, 2024
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial SpondyloarthritisSherry Rohekar, Jordi Pardo Pardo, Reza Mirza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2012
An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trialFlorence de Fraipont, Guénaëlle Levallet, Christian Creveuil, et al.
Clinical and Translational Gastroenterology|December 8, 2025
IMPACT OF ENDOMETRIOSIS ON THE PROGRESSION OF INFLAMMATORY BOWEL DISEASES: A MULTICENTER RETROSPECTIVE STUDYLucas Guillo, Oumaya El Oumami, Philippe Seksik, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
The Journal of Rheumatology|July 1, 2025
Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA)Denis Choquette, Dafna D Gladman, Robert D Inman, et al.
Molecular Systems Biology|September 4, 2008
InnateDB: facilitating systems-level analyses of the mammalian innate immune responseDavid J Lynn, Geoffrey L Winsor, Calvin Chan, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1)Michèle Beau-Faller, Armelle Degeorges, Estelle Rolland, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre StudyMathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Pageof 8